Affiliation:
1. Department of Neurology; University Medicine Greifswald; Greifswald Germany
2. Institute of Community Medicine; University Medicine Greifswald; Greifswald Germany
3. Department of Neurology; Carl-Thiem-Klinikum Cottbus; Cottbus Germany
Funder
Studienstiftung des Deutschen Volkes
DOMAGK program of the Medical Faculty of the University Greifswald
National Institute of Neurological Disorders and Stroke
Bundesministerium für Bildung und Forschung
Federal State of Mecklenburg-West Pomerania, Germany
Siemens Healthcare, Erlangen, Germany
Bayer Schering
Biogen Idec
Genzyme
Merck Serono
Novartis
Teva
Reference34 articles.
1. Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life;Allart;Journal of Neurology,2015
2. Chan , A. Flachenecker , P. Gold , R. Haghikia , A. Hellwig , K. Hemmer , B. Zipp , F. 2012 DGN/KKNMS Leitlinie zur Diagnose und Therapie der MS http://wwwdgnorg/images/stories/dgn/leitlinien/LL_MS_Neu/DGN-KKNMS_MS-LL_20120809_frei_neu4pdf11012013
3. Development of a multiple sclerosis functional composite as a clinical trial outcome measure;Cutter;Brain,1999
4. Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis;Davis;Annals of Neurology,1990
5. 4-Aminopyridine induces functional improvement in multiple sclerosis patients: a neurophysiological study;Diemen;Journal of the Neurological Sciences,1993
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献